|
(PQ#9) Promoting Axon Stability to Prevent Therapy-induced Peripheral Neuropathy
|
5R01CA219866-02
|
$465,400
|
DIANTONIO, AARON
|
WASHINGTON UNIVERSITY
|
|
(PQ5) Contribution of mitochondrial pathways to metabolic heterogeneity in molecular subtypes of Diffuse Large B Cell Lymphoma
|
1R01CA219850-01A1
|
$558,022
|
DANIAL, NIKA
|
DANA-FARBER CANCER INST
|
|
(PQ9)A redox-mediated mechanism of chemotherapy-induced cognitive impairment
|
5R01CA217934-02
|
$463,899
|
ST CLAIR, DARET
|
UNIVERSITY OF KENTUCKY
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120 02060
|
$79,723
|
Rothman, Nat
|
DCEG (NCI)
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5U01CA164974-08
|
$3,131,894
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1
|
ZIA BC 011064
|
$106,356
|
Mock, Beverly
|
CCR (NCI)
|
|
A multi-center international hospital-based case-control study of lymphoma in Asi
|
ZIA CP010136 10512
|
$1,398,817
|
Lan, Qing
|
DCEG (NCI)
|
|
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose
|
5R01CA190696-05
|
$299,009
|
SCHATZ, JONATHAN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease
|
5R01CA201719-03
|
$361,510
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
|
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL
|
5R01CA196266-03
|
$860,660
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
3R21CA205106-02S1
|
$77,331
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
5R21CA205106-02
|
$176,605
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Phase I trial combining IV fenretinide and IV safingol to target overproduction
|
5R44CA183316-03
|
$473,425
|
SIMPSON, WILLIAM
|
CERRX, INC.
|
|
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles
|
5F30CA221250-02
|
$49,524
|
SCHNORENBERG, MATHEW
|
UNIVERSITY OF CHICAGO
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$305,473
|
Tosato, Giovanna
|
CCR (NCI)
|
|
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors
|
5R21CA198237-03
|
$79,570
|
DANHAUER, SUZANNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S1
|
$244,519
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S2
|
$55,717
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S3
|
$65,235
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-42
|
$7,716,753
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$374,676
|
Aplan, Peter
|
CCR (NCI)
|
|
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
|
5U54CA190152-05
|
$745,654
|
GOPAL, SATISH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Agricultural Cohort Consortium
|
ZIA CP010119 10537
|
$45,135
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture
|
ZIA CP010119 10527
|
$813,241
|
Hofmann, Jonathan
|
DCEG (NCI)
|
|
AIDS Malignancy Consortium (AMC)
|
3UM1CA121947-12S2
|
$25,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Consortium (AMC)
|
5UM1CA121947-12
|
$23,766,226
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S1
|
$3,249,644
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S2
|
$1,000,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011415
|
$19,101
|
Kochenderfer, James
|
CCR (NCI)
|
|
Allotransplant for DOCK8 deficiency
|
ZIA BC 011374
|
$74,528
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Alpha Radioimmunotherapy for Lymphoma Treatment
|
5R01CA172582-05
|
$634,846
|
SANDMAIER, BRENDA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Alternative End-Joining in DNA Repair and Chromosomal Translocations
|
5F30CA189740-05
|
$49,524
|
KUMAR, VIPUL
|
HARVARD MEDICAL SCHOOL
|
|
Ambient dioxin exposure and cancer risk in women (IWHS and AHS)
|
ZIA CP010125 10712
|
$40,865
|
Jones, Rena
|
DCEG (NCI)
|
|
Analysis and Therapeutic Targeting Non-proteolytic Protein Ubiquitination in Diffuse Large B Cell Lymphoma
|
5K22CA197014-03
|
$194,616
|
YANG, YIBIN
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
Barr, Frederic
|
CCR (NCI)
|
|
Animal Model and Genotyping Core Support Facility
|
ZIC BC 011047
|
$775,353
|
DuBois, Wendy
|
CCR (NCI)
|
|
Annual International Primary CNS Lymphoma Collaborative Group Meeting
|
2R13CA124293-11
|
$5,000
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma
|
5R44CA144104-06
|
$943,738
|
KLINGHOFFER, RICHARD
|
PRESAGE BIOSCIENCES, INC.
|
|
Assisted Network-based Analysis of Cancer Gene Expression Studies
|
5R03CA216017-02
|
$83,750
|
MA, SHUANGGE
|
YALE UNIVERSITY
|
|
ATBC Lymphoma Studies
|
ZIA CP010195 10733
|
$96,076
|
Berndt, Sonja
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195 03031
|
$738,165
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,857,052
|
Custer, Mary
|
CCR (NCI)
|
|
BCR Signaling in ABC DLBCL
|
ZIA BC 011354
|
$112,802
|
Wilson, Wyndham
|
CCR (NCI)
|
|
BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma
|
5R01CA210250-02
|
$390,134
|
BHALLA, KAPIL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biochemical Basis of T Cell Activation
|
ZIA BC 010304
|
$1,382,902
|
Samelson, Lawrence
|
CCR (NCI)
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
5U54CA190146-05
|
$687,761
|
PHIPPS, WARREN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biological and Functional Significance of Lymphoma-Associated Macrophages in the Pathophysiology of Mantle Cell Lymphoma
|
1R21CA222438-01A1
|
$208,800
|
FORD, RICHARD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Biology and Transplantation of the Hematopoietic Stem Cell
|
5P01CA065493-24
|
$1,914,832
|
WAGNER, JOHN
|
UNIVERSITY OF MINNESOTA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|